证券之星消息，8月19日家居用品板块较上一交易日上涨0.58%，帝欧家居领涨。当日上证指数报收于 3727.29，下跌0.02%。深证成指报收于11821.63，下跌0.12%。家居用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002798 | 帝欧家居 | 7.00 | 8.19% | 33.30万 | 2.27亿 | | 605155 | 西大门 | 14.59 | 7.68% | 12.47万 | 1.77亿 | | 603992 | 松穀科技 | 29.06 | 6.92% | 11.56万 | 3.21亿 | | 603848 | 好太太 | 22.35 | 6.43% | 7.41万 | 1.60亿 | | 301055 | 张小泉 | 20.60 | 5.42% | 5.63万 | 1.14亿 | | 603268 | *ST松发 | 56.70 | 5.00% | 2.70万 | 1.52亿 | | 603021 | ST华鹏 | 4.26 | 4.9 ...

控股股东、实际控制人及其一致行动人增持公司股份 的 法律意见书 北京市竞天公诚律师事务所 关于广东四通集团股份有限公司 控股股东、实际控制人及其一致行动人增持公司股份的 法律意见书 致：广东四通集团股份有限公司 北京市竞天公诚律师事务所（以下简称"本所"）接受广东四通集团股份有 限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 中国证券监督管理委员会（以下简称"中国证监会"）发布的《上市公司收购管 理办法》（以下简称"《收购管理办法》"）等相关法律、法规和规范性文件的 规定，对公司控股股东、实际控制人黄建平及其一致行动人谢悦增、邓建华（以 下合称"增持人"）在2025年2月12日至2025年8月12日期间增持公司股份（以下 简称"本次增持"）相关事宜出具本法律意见书。 中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层 邮政编码 100025 电话: (86-10) 5809-1000 传真: (86-10) 5809-1100 北京市竞天公诚律师事务所 关于广东四通集团股份有限公司 就公司及增持人提 ...

证券代码：603838 证券简称：*ST 四通 公告编号：2025-034 广东四通集团股份有限公司 增持主体(及其一致行 动人)持股数量 增持计划完成后 增持主体（及其一致行 36.59% 关于控股股东、实际控制人及其一致行动人增持计划 实施完毕暨增持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 增持主体名称 黄建平 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 控股股东或实控人 | ?是 | | ?否 | | | | | | 控股股东或实控人的一致行动人 | | | | ?是 | ?否 | | | | 增持主体身份 | | | | | | | | | 直接持股 | 5%以上股东 ?是 | | ?否 | | | | | | 董事、监事和高级管理人员 | | | ?是 | | ?否 | | | | ?其他：__________ | | | | | | | | | 增持前持股数量 | 88,53 ...

证券代码：603838 证券简称：*ST 四通 公告编号：2025-034 广东四通集团股份有限公司 关于控股股东、实际控制人及其一致行动人增持计划 实施完毕暨增持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 增持主体名称 | 黄建平 | | | | --- | --- | --- | --- | | 增持主体身份 | 控股股东或实控人 | 是 | 否 | | | 控股股东或实控人的一致行动人 | 是 | 否 | | | 直接持股 5%以上股东 | 是 | 否 | | | 董事、监事和高级管理人员 | 是 | 否 | 一、增持主体的基本情况 上述增持主体存在一致行动人： | | 股东名称 | 持股数量 | 持股比例 | 一致行动关系形成原因 | | --- | --- | --- | --- | --- | | | | （股） | | | | 第一组 | 黄建平 | 90,418,032 | 28.25% | 签署一致行动协议 | | | 谢悦增 | 13,334, ...

中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层 邮政编码 100025 电话: (86-10) 5809-1000 传真: (86-10) 5809-1100 关于广东四通集团股份有限公司 控股股东、实际控制人及其一致行动人增持公司股份 的 法律意见书 2025 年 8 月 北京市竞天公诚律师事务所 关于广东四通集团股份有限公司 控股股东、实际控制人及其一致行动人增持公司股份的 法律意见书 致：广东四通集团股份有限公司 北京市竞天公诚律师事务所 北京市竞天公诚律师事务所（以下简称"本所"）接受广东四通集团股份有 限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 中国证券监督管理委员会（以下简称"中国证监会"）发布的《上市公司收购管 理办法》（以下简称"《收购管理办法》"）等相关法律、法规和规范性文件的 规定，对公司控股股东、实际控制人黄建平及其一致行动人谢悦增、邓建华（以 下合称"增持人"）在2025年2月12日至2025年8月12日期间增持公司股份（以下 简称"本次增持"）相关事宜出具本法律意见 ...

格隆汇8月12日丨*ST四通(603838.SH)公布，截至本公告披露日，黄建平先生以集中竞价交易方式累计 增持公司股份188.4万股，占公司总股本的0.59%，累计增持成交金额为1,018.15万元（不含交易费 用），本次增持计划实施完毕。 ...

Group 1 - The core point of the announcement is that the controlling shareholder, Huang Jianping, has completed a share buyback of approximately 1.88 million shares, accounting for 0.59% of the total share capital, with a total transaction amount of 10.18 million yuan [2] Group 2 - For the fiscal year 2024, the revenue composition of *ST Sihua is as follows: the ceramics industry accounts for 85.89%, the zirconium industry accounts for 13.93%, and other businesses account for 0.17% [2]

Core Insights - As of July 25, 16 companies have released their semi-annual reports for 2025, with 12 reporting year-on-year profit growth and 4 showing declines [1] - Among these, 10 companies experienced year-on-year revenue growth, while 6 reported declines [1] - Eight companies, including Zhimingda, saw both profit and revenue growth, while two companies, including Zhongyan Chemical, reported declines in both metrics [1] - Three companies achieved profit growth exceeding 100%, with Zhimingda leading at a staggering 2147.93% increase [1] Company Performance Summary - Zhimingda (688636): Earnings per share of 0.2284, net profit of 38.298 million, net profit growth of 2147.93%, and revenue of 294.7564 million with a growth of 84.83% [1] - Wohua Medicine (002107): Earnings per share of 0.0800, net profit of 44.6764 million, net profit growth of 303.16%, and revenue of 425.3585 million with a growth of 7.64% [1] - Shentong Technology (605228): Earnings per share of 0.1500, net profit of 64.278 million, net profit growth of 111.09%, and revenue of 815.7269 million with a growth of 22.46% [1] - Changchuan Technology (300604): Earnings per share of 0.6800, net profit of 427.0218 million, net profit growth of 98.73%, and revenue of 2.1668482 billion with a growth of 41.80% [1] - Minshida (833394): Earnings per share of 0.4300, net profit of 63.0278 million, net profit growth of 42.28%, and revenue of 237.4942 million with a growth of 27.91% [1] - Ruigu Mould (002997): Earnings per share of 1.0800, net profit of 226.9641 million, net profit growth of 40.33%, and revenue of 1.6623784 billion with a growth of 48.30% [1] - Gaoneng Environment (603588): Earnings per share of 0.3290, net profit of 502.4205 million, net profit growth of 20.85%, and revenue of 6.7000252 billion with a decline of 11.20% [1] - Zhongyan Chemical (600328): Earnings per share of 0.0359, net profit of 52.7155 million, net profit decline of 88.04%, and revenue of 5.9977208 billion with a decline of 5.76% [1]

Core Insights - As of July 22, 9 companies have released their semi-annual reports for 2025, with 6 reporting year-on-year profit growth and 8 showing revenue growth [1] - Notably, WoHua Pharmaceutical achieved the highest profit growth rate of 303.16% [1] Company Performance Summary - **WoHua Pharmaceutical (002107)**: - Earnings per share: 0.0800 - Net profit: 44.68 million - Net profit growth: 303.16% - Revenue: 425.36 million - Revenue growth: 7.64% [1] - **Shentong Technology (605228)**: - Earnings per share: 0.1500 - Net profit: 64.28 million - Net profit growth: 111.09% - Revenue: 815.73 million - Revenue growth: 22.46% [1] - **Changchuan Technology (300604)**: - Earnings per share: 0.6800 - Net profit: 427.02 million - Net profit growth: 98.73% - Revenue: 2166.85 million - Revenue growth: 41.80% [1] - **Ruihu Mould (002997)**: - Earnings per share: 1.0800 - Net profit: 226.96 million - Net profit growth: 40.33% - Revenue: 1662.38 million - Revenue growth: 48.30% [1] - **ST Lingda (300125)**: - Earnings per share: -0.3917 - Net profit: -104.83 million - Net profit growth: 37.56% - Revenue: 59.93 million - Revenue growth: 72.39% [1] - **Jucan Optoelectronics (300708)**: - Earnings per share: 0.1700 - Net profit: 116.97 million - Net profit growth: 3.43% - Revenue: 1594.04 million - Revenue growth: 19.51% [1] - **Haitong Development (603162)**: - Earnings per share: 0.1000 - Net profit: 86.87 million - Net profit growth: -64.14% - Revenue: 1800.31 million - Revenue growth: 6.74% [1] - **ST Sitong (603838)**: - Earnings per share: -0.0506 - Net profit: -16.20 million - Net profit growth: -78.33% - Revenue: 173.73 million - Revenue growth: 75.88% [1] - **Zhongyan Chemical (600328)**: - Earnings per share: 0.0359 - Net profit: 52.72 million - Net profit growth: -88.04% - Revenue: 5997.72 million - Revenue growth: -5.76% [1]

Summary of Key Points Core Viewpoint - The company has announced the provision for asset impairment amounting to 2,421,185.91 yuan, reflecting a cautious approach to accurately represent its financial status and operational results [1][2]. Group 1: Asset Impairment Provision Details - The company conducted a comprehensive review of its assets as of June 30, 2025, and decided to recognize an asset impairment provision of 2,421,185.91 yuan [1]. - The breakdown of the impairment provision includes: - Credit impairment losses totaling -1,010,804.55 yuan for accounts receivable - Other receivables impairment of -18,201.72 yuan - Inventory write-down provision of 3,450,192.18 yuan [1][2]. Group 2: Impact on Financial Status - The asset impairment provision will affect the company's total profit for the first half of 2025, aligning with the requirements of the Accounting Standards for Enterprises [2]. - The provision is intended to provide a true and fair view of the company's financial condition and operational results, ensuring reliable accounting information for investors [2]. Group 3: Approval Process - The asset impairment provision was approved during the tenth meeting of the fifth board of directors, confirming compliance with the Accounting Standards for Enterprises and the company's internal regulations [2]. - The supervisory board also agreed with the decision, emphasizing that the provision reflects the actual asset situation and adheres to legal and regulatory procedures [2].